Serum receptor activator of nuclear factor kappa-Β ligand/osteoprotegerin ratio correlates with severity and suggests fracture's risk in older women with atopic dermatitis

Allergy. 2021 Oct;76(10):3220-3223. doi: 10.1111/all.14971. Epub 2021 Jun 15.

Authors

Takashi Sakai^{1

2}, Nadine Herrmann¹, Laura Maintz¹, Tim Joachim Nümm¹, Thomas Welchowski^{1

3}, Thomas Bieber¹

Affiliations

¹ Department of Dermatology and Allergy, Christine Kühne-Center for Allergy Research and Education (CK-CARE), University Hospital Bonn, Bonn, Germany.
² Department of Dermatology, Faculty of Medicine, Oita University, Oita, Japan.
³ Department of Medical Biometry, Informatics and Epidemiology, University Hospital Bonn, Bonn, Germany.

PMID: 34080196
DOI: 10.1111/all.14971

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Aged
Dermatitis, Atopic* / diagnosis
Dermatitis, Atopic* / epidemiology
Eczema*
Female
Humans
Ligands
NF-kappa B
Osteoprotegerin
RANK Ligand

Substances

Ligands
NF-kappa B
Osteoprotegerin
RANK Ligand